Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment: monoclonal antibodies

Australia

• National Breast and Ovarian Cancer Centre
  • Trastuzumab for HER2-positive breast cancer: a systematic review [2009]
  • Summary for General Practitioners about the breast cancer drug Trastuzumab (Herceptin®) [2009]
  • Recommendations for Trastuzumab (Herceptin®) for treatment of HER2-positive breast cancer [2009]

Canada

• Cancer Care Ontario
  • The use of Bevacizumab in Metastatic Breast Cancer [2009]
  • The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer : a clinical practice guideline [2007]

Sweden

• Swedish Council on Technology Assessment in Health Care
  • Trastuzumab (herceptin) for metastasized breast cancer [2001]

United Kingdom

• Centre for Reviews and Dissemination, University of York
  • Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage [2008]

• Health Technology Assessment
  • Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal [2009]

• National Institute for Health and Clinical Excellence
  • Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal) [2008]
  • Breast cancer (early) - trastuzumab [2006]
  • Breast cancer - trastuzumab [2002]

United States of America

• National Guideline Clearinghouse
  • The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer: a clinical practice guideline. Program in Evidence-based Care [2006]
  • The role of trastuzumab (Herceptin®) in the treatment of women with HER2/neu-overexpressing metastatic breast cancer. Program in Evidence-based Care [2003]

Articles in journals

• Annals of Oncology
  • Adjuvant trastuzumab in early breast cancer [2006]

• Breast Cancer
  • Vascular endothelial growth factor and bevacitumab in breast cancer [2007]
  • Perspective of trastuzumab treatment [2007]
  • Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways [2007]

• Canadian Medical Association Journal
  • Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis [2007]

• Circulation
  • Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity [2000]

• Frontiers in Bioscience
  • Her2 cross talk and therapeutic resistance in breast cancer [2008]

• Journal of Cancer Research and Therapeutics
  • Trastuzumab: Is the new evidence revolutionary? [2006]

• Mayo Clinic Proceedings
  • Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads [2008]

{Related topics}

• Guidelines
  • Breast cancer treatment